2-(1H-indolylsulfanyl)-aryl amine derivatives

Details 2-(1H-indolylsulfanyl)-aryl amine derivatives 2-(1H-indolylsulfanyl)-aryl amine derivatives

2006-06-14

2009-12-08

Anderson, Rebecca L (Department: 1626)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C514S418000

Reexamination Certificate

active

07629473

ABSTRACT:
The present invention relates to compounds of formula IVand their use.

REFERENCES:
patent: 3803143 (1974-04-01), Tanaka et al.
patent: 4018830 (1977-04-01), Christy et al.
patent: 4055665 (1977-10-01), Christy et al.
patent: 4056632 (1977-11-01), Mehta et al.
patent: 4198417 (1980-04-01), Ong et al.
patent: 4241071 (1980-12-01), Martin et al.
patent: 5095039 (1992-03-01), Mehta et al.
patent: 5945425 (1999-08-01), Moormann et al.
patent: 6410736 (2002-06-01), Howard et al.
patent: 6436938 (2002-08-01), Howard et al.
patent: 6455738 (2002-09-01), Dubac et al.
patent: 6509340 (2003-01-01), Van Amsterdam et al.
patent: 6596741 (2003-07-01), Howard et al.
patent: 6906078 (2005-06-01), Moorman et al.
patent: 7189501 (2007-03-01), Makuta et al.
patent: 7199147 (2007-04-01), Imazaki et al.
patent: 7217732 (2007-05-01), Kozlowski et al.
patent: 7229751 (2007-06-01), Kimura et al.
patent: 7247651 (2007-07-01), Madera et al.
patent: 2002/0173524 (2002-11-01), Collins et al.
patent: 2003/0187023 (2003-10-01), Kubo et al.
patent: 2003/0207894 (2003-11-01), Theodoridis et al.
patent: 2004/0009959 (2004-01-01), Potter et al.
patent: 2004/0014774 (2004-01-01), Myers et al.
patent: 2004/0023010 (2004-02-01), Bulovic et al.
patent: 2004/0039035 (2004-02-01), Collins et al.
patent: 2004/0072844 (2004-04-01), Madera et al.
patent: 2004/0077854 (2004-04-01), Halazy et al.
patent: 2004/0132778 (2004-07-01), Lacadie et al.
patent: 2004/0137389 (2004-07-01), Fukui et al.
patent: 2004/0176426 (2004-09-01), Houze et al.
patent: 2004/0186148 (2004-09-01), Shankar et al.
patent: 2004/0192664 (2004-09-01), Kunz et al.
patent: 2004/0204451 (2004-10-01), Lacadie et al.
patent: 2004/0209936 (2004-10-01), Bratton et al.
patent: 2004/0220237 (2004-11-01), Fu et al.
patent: 2004/0266732 (2004-12-01), Galvez et al.
patent: 2005/0107599 (2005-05-01), Makioka et al.
patent: 2005/0123501 (2005-06-01), Lewis
patent: 2005/0136065 (2005-06-01), Valiante, Jr.
patent: 2005/0152859 (2005-07-01), Dooley et al.
patent: 2005/0153980 (2005-07-01), Schadt, Jr. et al.
patent: 2005/0159556 (2005-07-01), Lewis et al.
patent: 2005/0189519 (2005-09-01), Gothe et al.
patent: 2005/0206994 (2005-09-01), Kokeguchi et al.
patent: 2005/0228020 (2005-10-01), Miyamoto et al.
patent: 2005/0238992 (2005-10-01), Kodama
patent: 2005/0250794 (2005-11-01), Napper et al.
patent: 2005/0261298 (2005-11-01), Solow-Cordero et al.
patent: 2005/0282861 (2005-12-01), Friary et al.
patent: 2006/0030593 (2006-02-01), Bernotas et al.
patent: 2006/0069203 (2006-03-01), Lewis et al.
patent: 2006/0135540 (2006-06-01), Lin et al.
patent: 2006/0141286 (2006-06-01), Tada et al.
patent: 2006/0148801 (2006-07-01), Hsieh et al.
patent: 2006/0216546 (2006-09-01), Tada
patent: 2006/0276440 (2006-12-01), An et al.
patent: 2006/0287386 (2006-12-01), Kehler et al.
patent: 2007/0004923 (2007-01-01), Kobayashi et al.
patent: 2007/0054904 (2007-03-01), Knolle et al.
patent: 2007/0060595 (2007-03-01), Yoshizawa et al.
patent: 2008/0176922 (2008-08-01), Kehler et al.
patent: 0 273 199 (1988-07-01), None
patent: 0 396 827 (1990-11-01), None
patent: 0 402 097 (1990-12-01), None
patent: 0 755 923 (1997-01-01), None
patent: 0 814 084 (1997-12-01), None
patent: 0 921 124 (1999-06-01), None
patent: 1 793 272 (2007-06-01), None
patent: WO 93/11106 (1993-06-01), None
patent: WO 93/12080 (1993-06-01), None
patent: WO 94/14770 (1994-07-01), None
patent: WO 97/17325 (1997-05-01), None
patent: WO 97//17352 (1997-05-01), None
patent: WO 97/48698 (1997-12-01), None
patent: WO 98/08817 (1998-03-01), None
patent: WO 00/59878 (2000-10-01), None
patent: WO 00/66537 (2000-11-01), None
patent: WO 01/10842 (2001-02-01), None
patent: WO 01/27068 (2001-04-01), None
patent: WO 01/49677 (2001-07-01), None
patent: WO 01/49678 (2001-07-01), None
patent: WO 01/49679 (2001-07-01), None
patent: WO 02/40024 (2002-05-01), None
patent: WO 02/062766 (2002-08-01), None
patent: WO 02/098857 (2002-12-01), None
patent: WO 03/029232 (2003-04-01), None
patent: WO 03/055873 (2003-07-01), None
patent: WO 2005/061455 (2005-07-01), None
patent: WO 2006/006172 (2006-01-01), None
patent: WO 2006/007843 (2006-01-01), None
patent: WO 2006/018850 (2006-02-01), None
patent: WO 2006/038741 (2006-04-01), None
patent: WO 2006/063606 (2006-06-01), None
patent: WO 2006/098380 (2006-09-01), None
A. Burger, Isosterism and bioisosterism in drug design. Prog. Drug Res. 37 (1991), pp. 287-371).
Jackson et al. (CAPLUS Abstract of: Journal of Chemical Research, Synopses (1988), (9), 272-3).
Jackson, A., et al., “Electrophilic Substitution in Indoles Part 16: The Formation of Indolobenzothiazines and Indolobenzothiazepines by Intramolecular Cyclisation of (o-Nitrophenylthio)Indoles”, J. Chem. Res. Miniprint, vol. 9, 1988, pp. 2017-2063.
Ragno, R., et al., “Docking and 3-D QSAR Studies on Indolyl Aryl Sulfones. Binding Mode Exploration at the HIV-1 Reverse Transcriptase Non-Nucleoside Binnding Site and Design of Highly Active N-(2-Hydroxyethyl)carboxamide and N-(2-hydroxyethyl)carbohydrazide Derivatives”, J. Med. Chem., vol. 48. No. 1, 2005, pp. 213-223.
Silvestri, R., et al., “Novel Indolyl Aryl Sulfones Active Against HIV-1 Carrying NNRTI Resistance Mutations: Synthesis and SAR Studies”, J. Med. Chem., vol. 46, 2003, pp. 2482-2493.
Edmond, P., et al. “Substituted Diphenyl Sulfides as Selective Serotonin Transporter Ligands: Synthesis and In Vitro Evaluation”, J. Med. Chem., 2002, vol. 45, pp. 1253-1258.
Jilek, J., et al. “Potential Antidepressants: 2-(Methoxy- And Hydroxy-Phenylthio)Benzylamines As Selective Inhibitors Of 5-Hydroxytryptamine Re-uptake In the Brain”, Collect. Czech. Chem. Commun., 1989, vol. 54, pp. 3294-3338.
Sindelar, K., et al. “Potential Antidepressants And Inhibitors Of 5-Hydroxy-Tryptamine And Noradrenaline Re-uptake In The Brain: N,N-Dimethyl-(Arylthio)Thenylamines And N,N-Dimethyl-2-(Thienylthio)Benzylamines”, Collect. Czech. Chem. Commun., 1991, vol. 56, pp. 449-458.
Oya, S., et al. “A New Single-Photon Emission Computed Tomography Imaging Agent For Serotonin Transporters: [123I] IDAM, 5-iodo-2-((2-((dimethylamino)methyl)-phenyl)thio)benzyl Alcohol”, J. Med. Chem., 1999, vol. 42(3), pp. 333-335.
Oya, S., et al. “New PET Imaging Agent for the Serotonin Transporter: [18F]ACF (2-[(2-Amino-4-chloro-5-fluorophenyl)thio]-N,N-dimethyl-benzenmethanamine)”, J. Med. Chem., 2002, vol. 45, pp. 4716-4723.
Axford, L., et al. “Bicyclo[2.2.1]heptanes as Novel Triple Re-uptake Inhibitors for the Treatment of Depression” Bioorganic & Medicinal Chemistry Letters, 2003, pp. 3277-3280, vol. 13.
Hawkins, D.G., et al. “Competitive Cyclisation of Singlet and Triplet Nitrenes. Part 7. Reaction Pathways of 2-Azidophenyl Benzothienyl Azides”, Journal of the Chemical Society, Perkin Transactions I: Organic and Bio-Organic Chemistry, 1979, pp. 3207-3210, No. 12.
Martin, L., et al. “Synthesis of Spiro[isobenzofuran-1(3H),4′piperedines] as potential Central Nervous System Agents. Conformationally Mobile Analogues Derived by Furan Ring Opening”, J. Med. Chem., 1979, pp. 1347-1354, vol. 22, No. 11.
Abstract and STN Search Report cited in the Jul. 10, 2008 Office Action in connection with parallel U.S. Appl. No. 11/452,823.
Mitra, et al.; “Thiophenes & Thiapyrans: Part XVII—Thieno-(2:3-b)-thionaphtheno & Thionaphtheno-(2:3-b)-thionaphthene”, Journal of Scientific & Industrial Research., 1957, 16B:348-54.
Sejberg, J. Synth[e]sis of 3- and 2-phenylsulfanyl-1H-indole [thesis] (English Translation). Lyngby (Denmark): Technical University of Denmark; Jan. 21, 2003. 102 pages (Tables 6, 7 and 8 are attached at the end of the document). Available from: Technical University of Denmark, Lyngby, DK; d991811.
Wong, D. T. “Duloxetine (LY 248686): an inhibitor of Serotonin and noradrenaline uptake and antidepressant drug candidate” Exp. Opin. Invest. Drugs, 1998, 7(10), 1691-1699.
Khan, et al. “Venlafaxine in Depressed Outpatients

Affiliated with

Also associated with

Rating

2-(1H-indolylsulfanyl)-aryl amine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2-(1H-indolylsulfanyl)-aryl amine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-(1H-indolylsulfanyl)-aryl amine derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4083933